Suchergebnisse - "O3J8G9O825"

PubPharm (4.581)

31

Physicochemical interaction of rifampicin and ritonavir-lopinavir solid dispersion : an in-vitro and ex-vivo investigation

enthalten in: Drug development and industrial pharmacy | 2024

von Nair, A. | Vullendula, S. | Yarlagadda, D. | +3

32

Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19

enthalten in: Journal of clinical pharmacology | 2024

von Singh, R. | LaBadie, R. | Toussi, S. | +4

33

Simnotrelvir as a potential treatment for COVID-19

enthalten in: Expert opinion on pharmacotherapy | 2024

von McCarthy, M.

34

Cost-Utility Model of Nirmatrelvir/Ritonavir in Brazil : Analysis of a Vaccinated Population

enthalten in: Value in health regional issues | 2024

von Fernandes, R. | Barros, B. | da Costa, M. | +4

35

Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19 : a three-case series

enthalten in: European journal of hospital pharmacy : science and practice | 2024

von Guzmán Cordero, C. | Saez-Torres de Vicente, M.

36

A pilot study on Paxlovid therapy for hemodialysis patients with severe acute respiratory syndrome coronavirus 2 infections

enthalten in: Frontiers of medicine | 2024

von Hao, X. | Bao, Z. | Dai, R. | +13

37

Paxlovid Is Effective but Underused-Here's What the Latest Research Says About Rebound and More

enthalten in: JAMA | 2024

von Rubin, R.

38

Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19 in the era of vaccination and Omicron : An updated meta-analysis

enthalten in: Journal of medical virology | 2024

von Ombelet, S. | Castanares-Zapatero, D. | Desimpel, F. | +3

39

Determining and Comparing the Real-World Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Patients Hospitalized With COVID-19

enthalten in: Journal of Korean medical science | 2024

von Jang, Y. | Oh, Y. | Kim, J.

40

Nirmatrelvir Resistance-de Novo E166V/L50V Mutations in an Immunocompromised Patient Treated With Prolonged Nirmatrelvir/Ritonavir Monotherapy Leading to Clinical and Virological Treatment Failure-a Case Report

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Zuckerman, N. | Bucris, E. | Keidar-Friedman, D. | +2